Minimizing Drug Adverse Events by Informing About the Nocebo Effect—An Experimental Study

Yiqi Pan, Timm Kinitz, Marin Stapic, +1

Frontiers in Psychiatry

Open-label placebos for menopausal hot flushes: a randomized controlled trial

Yiqi Pan, R. Meister, Bernd Löwe, +3

Scientific Reports

Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers

Yiyuan Pan, Yiqi Pan, Yue Cheng, +3

Cell & Bioscience

<p>MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer</p>

Yue Cheng, Yiqi Pan, Yiyuan Pan, +1

Cancer Management and Research

Optimizing expectations about endocrine treatment for breast cancer: Results of the randomized controlled psy-breast trial

Meike Shedden‐Mora, Yiqi Pan, Sarah R. Heisig, +5

Clinical Psychology in Europe

Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study

Yiqi Pan, Sarah R. Heisig, Pia von Blanckenburg, +4

Breast Cancer Research and Treatment

Substance Abuse-Related Self-Stigma in Women with Substance Use Disorder and Comorbid Posttraumatic Stress Disorder

Hanne Melchior, Paul Hüsing, Johanna Grundmann, +9

European Addiction Research

Informing About the Nocebo Effect Affects Patients’ Need for Information About Antidepressants—An Experimental Online Study

Yvonne Nestoriuc, Yiqi Pan, Timm Kinitz, +2

Frontiers in Psychiatry

Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial

Twyla Michnevich, Yiqi Pan, Armin Hendi, +3

BMC Cancer

Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) – study protocol of a randomized controlled trial with gastrointestinal cancer patients

Julia Quidde, Yiqi Pan, M. L. van der Salm, +5

BMC Cancer